MEC Plus

Esophageal and Gastric Cancer: New Developments
Esophageal and Gastric Cancer: New Developments
Syma Iqbal, MD
Colorectal Cancer: State of the Art
Colorectal Cancer: State of the Art
Heinz-Josef Lenz, MD, FACP
Colorectal Cancer: State of the Art
Colorectal Cancer: State of the Art
Heinz-Josef Lenz, MD, FACP
Pancreatic Cancer: Emerging Strategies
Pancreatic Cancer: Emerging Strategies
Vincent Chung, MD
Advances in Car-T Cells and Other Cellular Based Therapies
Advances in Car-T Cells and Other Cellular Based Therapies
Elizabeth Budde, MD, PhD
Management of Immune Related Adverse Events
Management of Immune Related Adverse Events
Elizabeth (Liz) Cooke, RN, NP, PhD
Management of Immune Related Adverse Events
Management of Immune Related Adverse Events
Elizabeth (Liz) Cooke, RN, NP, PhD
The Future of Biomarkers of Immunotherapy in Cancer
The Future of Biomarkers of Immunotherapy in Cancer
Peter P. Lee, MD
How I Treat Multiple Myeloma
How I Treat Multiple Myeloma
Aaron S. Rosenberg, MD, MS
How I Treat Multiple Myeloma
How I Treat Multiple Myeloma
Aaron S. Rosenberg, MD, MS
How I Treat Locally Advanced Head and Neck Cancer
How I Treat Locally Advanced Head and Neck Cancer
A. Dimitrios Colevas, MD
PK and PD Considerations in Early Phase Clinical Trials
PK and PD Considerations in Early Phase Clinical Trials
Timothy Synold, PharmD
Bayesian Designs in Clinical Trials
Bayesian Designs in Clinical Trials
Mark Krailo, PhD
Waldenstrom’s Macroglobulinemia
Waldenstrom’s Macroglobulinemia
Andrew Branagan, MD, PhD
Waldenstrom’s Macroglobulinemia
Waldenstrom’s Macroglobulinemia
Andrew Branagan, MD, PhD
Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL
Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL
William G. Wierda, MD, PhD